CELLERANT THERAPEUTICS INC

Organization

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Humanized anti-CLL-1 antibodies
- Patent number 11,072,662
- Issue date Jul 27, 2021
- Cellerant Therapeutics, Inc.
- Ying-Ping Jiang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoquinolidinobenzodiazepines
- Patent number 10,898,580
- Issue date Jan 26, 2021
- Cellerant Therapeutics, Inc.
- Jagath R. Junutula
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies specific for CLL-1
- Patent number 10,723,805
- Issue date Jul 28, 2020
- Cellerant Therapeutics, Inc.
- Ping Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-b...
- Patent number 10,350,218
- Issue date Jul 16, 2019
- Cellerant Therapeutics, Inc.
- Jagath R. Junutula
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that specifically bind to TIM3
- Patent number 10,301,394
- Issue date May 28, 2019
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoquinolidinobenzodiazepines
- Patent number 9,974,864
- Issue date May 22, 2018
- Cellerant Therapeutics, Inc.
- Jagath R. Junutula
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for CLL-1
- Patent number 9,850,314
- Issue date Dec 26, 2017
- Cellerant Therapeutics, Inc.
- Ping Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that specifically bind to TIM3
- Patent number 9,631,026
- Issue date Apr 25, 2017
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoquinolidinobenzodiazepines
- Patent number 9,504,694
- Issue date Nov 29, 2016
- Cellerant Therapeutics, Inc.
- Jagath R. Junutula
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine receptors associated with myelogenous haematological proli...
- Patent number 9,371,390
- Issue date Jun 21, 2016
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for CLL-1
- Patent number 9,163,090
- Issue date Oct 20, 2015
- Cellerant Therapeutics, Inc.
- Ping Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of expanding myeloid cell populations and uses thereof
- Patent number 8,877,495
- Issue date Nov 4, 2014
- Cellerant Therapeutics, Inc.
- Timothy C. Fong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that specifically bind to TIM3
- Patent number 8,841,418
- Issue date Sep 23, 2014
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating haematological proliferative...
- Patent number 8,715,619
- Issue date May 6, 2014
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytokine receptors associated with myelogenous haematological proli...
- Patent number 8,709,715
- Issue date Apr 29, 2014
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of expanding myeloid cell populations and uses thereof
- Patent number 8,481,315
- Issue date Jul 9, 2013
- Cellerant Therapeutics, Inc.
- Timothy C. Fong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for enhancing engraftment of hematopoietic...
- Patent number 8,383,095
- Issue date Feb 26, 2013
- Cellerant Therapeutics, Inc.
- Julie Lynne Christensen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
- Publication number 20220064600
- Publication date Mar 3, 2022
- Cellerant Therapeutics, Inc.
- Timothy C. Fong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOQUINOLIDINOBENZODIAZEPINE (IQB)-1(CHLOROMETHYL)-2,3-DIHYDRO-1H-B...
- Publication number 20200061079
- Publication date Feb 27, 2020
- Cellerant Therapeutics, Inc.
- Jagath R. JUNUTULA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-IL1-RAP ANTIBODIES
- Publication number 20190338038
- Publication date Nov 7, 2019
- Cellerant Therapeutics, Inc.
- Ying Ping Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
- Publication number 20190241872
- Publication date Aug 8, 2019
- Cellerant Therapeutics, Inc.
- Timothy C. Fong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
- Publication number 20190106680
- Publication date Apr 11, 2019
- Cellerant Therapeutics, Inc.
- Timothy C. Fong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HUMANIZED ANTI-CLL-1 ANTIBODIES
- Publication number 20180355044
- Publication date Dec 13, 2018
- Cellerant Therapeutics, Inc.
- Ying-Ping Jiang
- G01 - MEASURING TESTING
Information Patent Application
CYSTEINE-SUBSTITUTED IMMUNOGLOBULINS
- Publication number 20180312592
- Publication date Nov 1, 2018
- Cellerant Therapeutics, Inc.
- Jagath R. JUNUTULA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOQUINOLIDINOBENZODIAZEPINES
- Publication number 20180280529
- Publication date Oct 4, 2018
- Cellerant Therapeutics, Inc.
- JAGATH R. JUNUTULA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CLL-1
- Publication number 20180273633
- Publication date Sep 27, 2018
- Cellerant Therapeutics, Inc.
- Ping Jiang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOQUINOLIDINOBENZODIAZEPINE (IQB)-1(CHLOROMETHYL)-2,3-DIHYDRO-1H-B...
- Publication number 20180177795
- Publication date Jun 28, 2018
- Cellerant Therapeutics, Inc.
- Jagath R. JUNUTULA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOQUINOLIDINOBENZODIAZEPINES
- Publication number 20170157265
- Publication date Jun 8, 2017
- Cellerant Therapeutics, Inc.
- JAGATH R. JUNUTULA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOQUINOLIDINOBENZODIAZEPINES
- Publication number 20160271142
- Publication date Sep 22, 2016
- Cellerant Therapeutics, Inc.
- JAGATH R. JUNUTULA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES SPECIFIC FOR CLL-1
- Publication number 20150376290
- Publication date Dec 31, 2015
- Cellerant Therapeutics, Inc.
- Ping Jiang
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES THAT BIND MEMBRANE-BOUND IL1RAP
- Publication number 20150315279
- Publication date Nov 5, 2015
- Cellerant Therapeutics, Inc.
- Ying-Ping JIANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOKINE RECEPTORS ASSOCIATED WITH MYELOGENOUS HAEMATOLOGICAL PROLI...
- Publication number 20140335103
- Publication date Nov 13, 2014
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- G01 - MEASURING TESTING
Information Patent Application
MEGAKARYOCYTE PROGENITOR CELLS FOR PRODUCTION OF PLATELETS
- Publication number 20140205582
- Publication date Jul 24, 2014
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES SPECIFIC FOR CLL-1
- Publication number 20130295118
- Publication date Nov 7, 2013
- Cellerant Therapeutics, Inc.
- Ping Jiang
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING HAEMATOLOGICAL PROLIFERATIVE...
- Publication number 20130216558
- Publication date Aug 22, 2013
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
- Publication number 20130089527
- Publication date Apr 11, 2013
- Cellerant Therapeutics, Inc.
- Timothy C. Fong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES THAT SPECIFICALLY BIND TO TIM3
- Publication number 20130022623
- Publication date Jan 24, 2013
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF
- Publication number 20130004468
- Publication date Jan 3, 2013
- Cellerant Therapeutics, Inc.
- Timothy C. Fong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING HAEMATOLOGICAL PROLIFERATIVE...
- Publication number 20110059852
- Publication date Mar 10, 2011
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Immunoglobulin and/or Toll-Like Receptor Proteins Associated with M...
- Publication number 20110044894
- Publication date Feb 24, 2011
- Cellerant Therapeutics, Inc.
- Holger Karsunky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for treating haematological proliferative...
- Publication number 20080003224
- Publication date Jan 3, 2008
- Cellerant Therapeutics, Inc.
- Timothy C. Fong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Compositions for Enhancing Engraftment of Hematopoietic...
- Publication number 20070237752
- Publication date Oct 11, 2007
- Cellerant Therapeutics, Inc.
- Julie Lynne CHRISTENSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of expanding myeloid cell populations and uses thereof
- Publication number 20060134783
- Publication date Jun 22, 2006
- Cellerant Therapeutics, Inc.
- Timothy C. Fong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
76412826 - CELLERANT THERAPEUTICS
- Serial number 76412826
- Registration number 3142493
- Filing date May 22, 2002
- Celtrans LLC
- 42 - Scientific and technological services and research and design relating thereto

NIH Research Projectlast 12 months

processing...

Count: 17

Research Projects

Information Research Project
Novel Indication for Myeloid Progenitor Use: Induction of Tolerance...
- Application id 9618741
- Award notice date Dec 17, 2018
Information Research Project
Novel Indication for Myeloid Progenitor Use: Induction of Tolerance...
- Application id 9466026
- Award notice date Dec 26, 2017
Information Research Project
Novel indication for myeloid progenitor use: Induction of tolerance
- Application id 8591198
- Award notice date Jul 18, 2013
Information Research Project
Development of ex vivo Expanded Megakaryocyte Progenitors for Plate...
- Application id 7921802
- Award notice date Sep 17, 2009
Information Research Project
Attenuation of Radiation-Induced GI Injury by Cultured Myeloid Prog...
- Application id 7499744
- Award notice date Aug 20, 2008
Information Research Project
Development of ex vivo Expanded Megakaryocyte Progenitors for Plate...
- Application id 7555648
- Award notice date Jun 19, 2008
Information Research Project
Attenuation of Radiation-Induced GI Injury by Cultured Myeloid Prog...
- Application id 7218536
- Award notice date Sep 24, 2007
Information Research Project
Application of Expanded Myeloid Progenitors for Infection (Phase II)
- Application id 7276559
- Award notice date Jul 13, 2007
Information Research Project
Application of Expanded Myeloid Progenitors for Infection (Phase II)
- Application id 7159214
- Award notice date Aug 11, 2006
Information Research Project
Expansion of HSC for rescue in biodefense applications
- Application id 6937761
- Award notice date Jul 15, 2005
Information Research Project
Application of expanded progenitors against infections
- Application id 6898069
- Award notice date Jun 8, 2005
Information Research Project
Expansion of HSC for rescue in biodefense applications
- Application id 6831916
- Award notice date Aug 15, 2004
Information Research Project
Validation of novel parallel hematopoietic cell sorter
- Application id 6645855
- Award notice date Jun 19, 2003
Information Research Project
Development of a Process for Generating Human MKP
- Application id 8722951
Information Research Project
IGF::OT::IGF: SBIR PHASE II, TOPIC 326: DEVELOPMENT OF NOVEL THERAP...
- Application id 9361090
Information Research Project
Development of a Process for Generating Human MKP
- Application id 8566123
Information Research Project
Development of IL1RAP antibodies targeting AML CS
- Application id 8947448

CELLERANT THERAPEUTICS INC

Organization

Patents Grantslast 30 patents

Humanized anti-CLL-1 antibodies

Isoquinolidinobenzodiazepines

Antibodies specific for CLL-1

Isoquinolidinobenzodiazepine (IQB)-1(chloromethyl)-2,3-dihydro-1H-b...

Antibodies that specifically bind to TIM3

Isoquinolidinobenzodiazepines

Antibodies specific for CLL-1

Antibodies that specifically bind to TIM3

Isoquinolidinobenzodiazepines

Cytokine receptors associated with myelogenous haematological proli...

Antibodies specific for CLL-1

Methods of expanding myeloid cell populations and uses thereof

Antibodies that specifically bind to TIM3

Compositions and methods for treating haematological proliferative...

Cytokine receptors associated with myelogenous haematological proli...

Methods of expanding myeloid cell populations and uses thereof

Methods and compositions for enhancing engraftment of hematopoietic...

Patents Applicationslast 30 patents

METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF

ISOQUINOLIDINOBENZODIAZEPINE (IQB)-1(CHLOROMETHYL)-2,3-DIHYDRO-1H-B...

ANTI-IL1-RAP ANTIBODIES

METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF

METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF

HUMANIZED ANTI-CLL-1 ANTIBODIES

CYSTEINE-SUBSTITUTED IMMUNOGLOBULINS

ISOQUINOLIDINOBENZODIAZEPINES

ANTIBODIES SPECIFIC FOR CLL-1

ISOQUINOLIDINOBENZODIAZEPINE (IQB)-1(CHLOROMETHYL)-2,3-DIHYDRO-1H-B...

ISOQUINOLIDINOBENZODIAZEPINES

ISOQUINOLIDINOBENZODIAZEPINES

ANTIBODIES SPECIFIC FOR CLL-1

ANTIBODIES THAT BIND MEMBRANE-BOUND IL1RAP

CYTOKINE RECEPTORS ASSOCIATED WITH MYELOGENOUS HAEMATOLOGICAL PROLI...

MEGAKARYOCYTE PROGENITOR CELLS FOR PRODUCTION OF PLATELETS

ANTIBODIES SPECIFIC FOR CLL-1

COMPOSITIONS AND METHODS FOR TREATING HAEMATOLOGICAL PROLIFERATIVE...

METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF

ANTIBODIES THAT SPECIFICALLY BIND TO TIM3

METHODS OF EXPANDING MYELOID CELL POPULATIONS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING HAEMATOLOGICAL PROLIFERATIVE...

Immunoglobulin and/or Toll-Like Receptor Proteins Associated with M...

Compositions and methods for treating haematological proliferative...

Methods and Compositions for Enhancing Engraftment of Hematopoietic...

Methods of expanding myeloid cell populations and uses thereof

Trademarklast 30 trademarks

76412826 - CELLERANT THERAPEUTICS

NIH Research Projectlast 12 months

Research Projects

Novel Indication for Myeloid Progenitor Use: Induction of Tolerance...

Novel Indication for Myeloid Progenitor Use: Induction of Tolerance...

Novel indication for myeloid progenitor use: Induction of tolerance

Development of ex vivo Expanded Megakaryocyte Progenitors for Plate...

Attenuation of Radiation-Induced GI Injury by Cultured Myeloid Prog...

Development of ex vivo Expanded Megakaryocyte Progenitors for Plate...

Attenuation of Radiation-Induced GI Injury by Cultured Myeloid Prog...

Application of Expanded Myeloid Progenitors for Infection (Phase II)

Application of Expanded Myeloid Progenitors for Infection (Phase II)

Expansion of HSC for rescue in biodefense applications

Application of expanded progenitors against infections

Expansion of HSC for rescue in biodefense applications

Validation of novel parallel hematopoietic cell sorter

Development of a Process for Generating Human MKP

IGF::OT::IGF: SBIR PHASE II, TOPIC 326: DEVELOPMENT OF NOVEL THERAP...

Development of a Process for Generating Human MKP

Development of IL1RAP antibodies targeting AML CS